Kimberly-Clark Corp Reports Q4 Revenue of $4.9 Billion, Slightly Above Estimates; Adjusted EPS of $1.50 Misses Expectations

GuruFocus
28 Jan

On January 28, 2025, Kimberly-Clark Corp (KMB, Financial) released its 8-K filing detailing its fourth quarter and full-year 2024 financial results. The company, a leading manufacturer in the tissue and hygiene sector with brands like Huggies, Kleenex, and Cottonelle, reported mixed results as it navigates its ongoing transformation strategy.

Performance Overview and Challenges

Kimberly-Clark Corp (KMB, Financial) reported fourth-quarter net sales of $4.9 billion, a slight decrease of 0.8% compared to the previous year. Despite this, organic sales grew by 2.3%, driven by a 1.5% increase in volume and a 0.6% rise in pricing. However, the company faced challenges from unfavorable currency exchange rates and the divestiture of its Personal Protective Equipment (PPE) business, which collectively reduced sales by approximately 3.1%.

The company's diluted earnings per share (EPS) for the quarter were $1.34, falling short of the analyst estimate of $1.51. On an adjusted basis, EPS was $1.50, a decrease of 0.7% from the previous year, primarily due to lower equity income despite higher adjusted operating profit.

Financial Achievements and Industry Impact

Kimberly-Clark's gross margin for the quarter was 34.0%, with an adjusted gross margin of 35.4%, reflecting a 50 basis point improvement from the prior year. This improvement was attributed to strong productivity gains, although it was partially offset by increased manufacturing costs and supply chain investments. The company's ability to maintain a robust gross margin is crucial in the consumer packaged goods industry, where cost management and efficiency are key to sustaining competitive advantage.

Key Financial Metrics

Operating profit for the fourth quarter was $548 million, with an adjusted operating profit of $684 million, marking a 2.1% increase from the previous year. This growth was supported by higher adjusted gross profit dollars, although it was partially offset by increased marketing, research, and general expenses.

Metric Q4 2024 Q4 2023 Change
Net Sales $4.9 billion $4.97 billion -0.8%
Gross Margin 34.0% 33.5% +50 bps
Operating Profit $548 million $670 million -18.2%
Diluted EPS $1.34 $1.50 -10.7%

Analysis and Future Outlook

Kimberly-Clark's performance in 2024 reflects the company's strategic focus on its Powering Care transformation initiative, which aims to enhance its competitive position through innovation and efficiency. Despite the challenges posed by currency fluctuations and divestitures, the company achieved significant productivity gains and maintained a strong gross margin.

Looking ahead, Kimberly-Clark anticipates continued organic growth and operating momentum in 2025, supported by its strategic initiatives. However, the company remains cautious about potential headwinds from currency translation and divestitures, which could impact its financial performance.

“2024 was a breakthrough year for Kimberly-Clark with the launch of our transformative, multi-year Powering Care strategy and successfully rewiring our organization into three powerhouse segments with world-class functional support,” said Kimberly-Clark Chairman and CEO, Mike Hsu.

Overall, Kimberly-Clark's results underscore the importance of strategic transformation in navigating market challenges and driving long-term growth in the consumer packaged goods industry.

Explore the complete 8-K earnings release (here) from Kimberly-Clark Corp for further details.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10